Search
2024
2023
-
Nov 05, 2024
YolTech and East China Normal University Publish Breakthrough Study on In Vivo Genome Editing for Blood DisordersRead More
-
Oct 31, 2024
YolTech Awarded Patent for Novel Lipid Nanoparticle Technology, Strengthening In-House Delivery CapabilitiesRead More
-
Oct 22, 2024
YolTech Publish Breakthrough Research on Novel Gene-Editing Strategy for Treating Primary Hyperoxaluria Type 1 in Molecular TherapyRead More
-
Sep 23, 2024
YolTech Receives U.S. FDA ODD for YOLT-203 in Treating PH1Read More
-
Sep 04, 2024
YolTech Receives U.S. FDA RPDD for YOLT-203 in Treating PH1Read More
